Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| ALKERMES | 13 | 8 | +1,52 % | ||
| IONIS PHARMACEUTICALS | 9 | - | +3,59 % | ||
| LARIMAR THERAPEUTICS | 8 | 4 | -5,20 % | ||
| RECURSION PHARMACEUTICALS | 8 | 3 | 0,00 % | ||
| REVOLUTION MEDICINES | 7 | 5 | -4,57 % | ||
| MIRUM PHARMACEUTICALS | 7 | 1 | 0,00 % | ||
| AURINIA PHARMACEUTICALS | 7 | - | +5,93 % | ||
| BEONE MEDICINES LTD ADR | 6 | 10 | -6,71 % | ||
| GILEAD SCIENCES | 6 | 5 | -0,34 % | ||
| PROTAGONIST THERAPEUTICS | 6 | 3 | +0,68 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13:06 | Viatris Non-GAAP EPS of $0.57 beats by $0.04, revenue of $3.7B beats by $170M | - | Seeking Alpha | ||
| 13:06 | Viatris maintains annual dividend at 48 cents for 2026 | 3 | Investing.com | ||
| 13:06 | NovoCure Earnings Report: Q4 Overview | - | Benzinga.com | ||
| 13:06 | Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update | 24 | Business Wire | Full year 2025 net revenues of $655 million and fourth quarter net revenues of $174 million Optune Pax approved by the U.S. FDA for the treatment of locally advanced pancreatic cancer, commercial... ► Artikel lesen | |
| 13:02 | NovoCure Ltd - 10-K, Annual Report | 1 | SEC Filings | ||
| 13:00 | Aclaris Therapeutics, Inc.: Aclaris Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update | 3 | GlobeNewswire (USA) | ||
| 13:00 | Indivior Pharmaceuticals, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 12:49 | Nuvalent, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 12:48 | Nuvalent GAAP EPS of -$1.58 misses by $0.09 | 3 | Seeking Alpha | ||
| 12:42 | Compass Pathways raises $200M from warrant exercises | 1 | Investing.com | ||
| 12:42 | Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug | 1 | Investing.com | ||
| 12:40 | Nuvalent, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 12:36 | Compass Pathfinder Limited: Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants | 141 | Business Wire | Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the exercise of 35,059,448 warrants, which were... ► Artikel lesen | |
| 12:35 | Nuvalent, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12:30 | Stifel raises Ionis Pharmaceuticals price target on pipeline outlook | 1 | Investing.com | ||
| 12:30 | Fortrea Holdings Non-GAAP EPS of $0.09 misses by $0.07, revenue of $660.5M misses by $4.72M | 2 | Seeking Alpha | ||
| 12:22 | Aurinia Pharma: EPS übertrifft Schätzungen um 1,38 $ - Umsatz besser als erwartet | 1 | Investing.com Deutsch | ||
| 12:21 | ARGENX SE - 6-K, Report of foreign issuer | 5 | SEC Filings | ||
| 12:18 | BeiGene Non-GAAP EPS of $1.95 beats by $0.65, revenue of $1.5B beats by $50M | 2 | Seeking Alpha | ||
| 12:10 | BeOne Medicines Ltd. - 10-K, Annual Report | 2 | SEC Filings |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.